The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Identification of SARS-CoV-2 inhibitors using lung and colonic organoids
Open accessAbstract
There is an urgent need to create novel models using human disease-relevant cells to study severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) biology and to facilitate drug screening. Here, as SARS-CoV-2 primarily infects the respiratory tract, we developed a lung organoid model using human pluripotent stem cells (hPSC-LOs). The hPSC-LOs (particularly alveolar type-II-like cells) are permissive to SARS-CoV-2 infection, and showed robust induction of chemokines following SARS-CoV-2 infection, similar to what is seen in patients with COVID-19. Nearly 25% of these patients also have gastrointestinal manifestations, which are associated with worse COVID-19 outcomes 1. We therefore also generated complementary hPSC-derived colonic organoids (hPSC-COs) to explore the response of colonic cells to SARS-CoV-2 infection. We found that multiple colonic cell types, especially enterocytes, express ACE2 and are permissive to SARS-CoV-2 infection. Using hPSC-LOs, we performed a high-throughput screen of drugs approved by the FDA (US Food and Drug Administration) and identified entry inhibitors of SARS-CoV-2, including imatinib, mycophenolic acid and quinacrine dihydrochloride. Treatment at physiologically relevant levels of these drugs significantly inhibited SARS-CoV-2 infection of both hPSC-LOs and hPSC-COs. Together, these data demonstrate that hPSC-LOs and hPSC-COs infected by SARS-CoV-2 can serve as disease models to study SARS-CoV-2 infection and provide a valuable resource for drug screening to identify candidate COVID-19 therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“high-throughput screens of ≥1,000 drugs approved by the FDA run on colonic and lung organoids identified several SARS-CoV-2 entry inhibitors such as imatinib, mycophenolic acid and quinacrine dihydrochloride111.”
From Human disease models in drug development (2023) · cites this paper as [111]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“amodiaquine (for example, NCT04532931, NCT04502342)51 and imatinib111 (for example, NCT04394416) have entered clinical trials.”
From Human disease models in drug development (2023) · cites this paper as [111]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Comprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405
Self-citationImbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222
Self-citationWebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs
Liao, Y., Wang, J., Jaehnig, E. J., Shi, Z., & Zhang, B. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz401 · Cited by 3,144
Cell entry mechanisms of SARS-CoV-2
Shang, J., Wan, Y., Luo, C., Ye, G., Geng, Q., Auerbach, A., & Li, F. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003138117 · Cited by 3,142
Monteil, V., Kwon, H., Prado, P., Hagelkrüys, A., Wimmer, R. A., Stahl, M., Leopoldi, A., Garreta, E., Hurtado del Pozo, C., Prosper, F., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.004 · Cited by 2,122
Pan, L., Mu, M., Yang, P., Sun, Y., Wang, R., Yan, J., Li, P., Hu, B., Wang, J., Hu, C., et al. (2020) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000620 · Cited by 1,823
A molecular cell atlas of the human lung from single-cell RNA sequencing
Travaglini, K. J., Nabhan, A. N., Penland, L., Sinha, R., Gillich, A., Sit, R. V., Chang, S., Conley, S. D., Mori, Y., Seita, J., et al. (2020) · Nature · doi:10.1038/s41586-020-2922-4 · Cited by 1,730
Cited by
Sorted by citations
Items 101–200 of 532
Zhou, H., Zhang, Q., Huang, W. T., Zhou, S., Wang, Y., Zeng, X., Wang, H., Xie, W., & Kong, H. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.80605 · Cited by 49
Self-citationWu, T.-H., Travaglini, K. J., Rustagi, A., Xu, D., Zhang, Y., Andronov, L. P., Jang, S., Gillich, A., Dehghannasiri, R., Martínez-Colón, G. J., et al. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20232192 · Cited by 56
Self-citationBioengineered Co-culture of organoids to recapitulate host-microbe interactions
Kim, M. B., Hwangbo, S., Jang, S., & Jo, Y. K. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100345 · Cited by 49
Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2
Touret, F., Driouich, J., Cochin, M., Petit, P.-R., Gilles, M., Barthélémy, K., Moureau, G., Mahon, F., Malvy, D. J.-M., Solas, C., et al. (2021) · Antiviral Research · doi:10.1016/j.antiviral.2021.105137 · Cited by 46
Wang, Z., Yang, L., & Zhao, X. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.08.029 · Cited by 46
Self-citationNovelli, G., Spitalieri, P., Murdocca, M., Centanini, E., & Sangiuolo, F. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1059579 · Cited by 43
Synthetic Matrices for Intestinal Organoid Culture: Implications for Better Performance
Poudel, H., Sanford, K., Szwedo, P. K., Pathak, R., & Ghosh, A. (2021) · ACS Omega · doi:10.1021/acsomega.1c05136 · Cited by 45
In Vitro Lung Models and Their Application to Study SARS-CoV-2 Pathogenesis and Disease
Heinen, N., Klöhn, M., Steinmann, E., & Pfaender, S. (2021) · Viruses · doi:10.3390/v13050792 · Cited by 41
Studying SARS-CoV-2 infectivity and therapeutic responses with complex organoids
Chen, K. G., Park, K., & Spence, J. R. (2021) · Nature Cell Biology · doi:10.1038/s41556-021-00721-x · Cited by 45
Hui, K. P. Y., Cheung, M.-C., Lai, K.-L., Ng, K., Ho, J. C.-W., Peiris, M. J. S., Nicholls, J. M., & Chan, M. C. W. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab406 · Cited by 44
Engineering in vitro immune-competent tissue models for testing and evaluation of therapeutics
Hammel, J. H., Zatorski, J. M., Cook, S. R., Pompano, R. R., & Munson, J. M. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114111 · Cited by 42
Harnessing the power of artificial intelligence for human living organoid research
Wang, H., Li, X., You, X., & Zhao, G. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.08.027 · Cited by 43
Self-citationApplication of lung microphysiological systems to COVID-19 modeling and drug discovery: a review
Sun, A., Hoffman, T., Luu, B. Q., Ashammakhi, N. A., & Li, S. (2021) · Bio-Design and Manufacturing · doi:10.1007/s42242-021-00136-5 · Cited by 42
Kronemberger, G. S., Carneiro, F. A., de Rezende, D. F., & Baptista, L. S. (2020) · Artificial Organs · doi:10.1111/aor.13880 · Cited by 40
Function of epithelial stem cell in the repair of alveolar injury
Chan, M., & Liu, Y. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02847-7 · Cited by 44
Self-citationProtein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics
Gupta, Y. A., Savytskyi, O. V., Coban, M., Venugopal, A., Pleqi, V., Weber, C. A., Chitale, R. A., Durvasula, R. V., Hopkins, C. E., Kempaiah, P., et al. (2022) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2022.101151 · Cited by 40
A novel, covalent broad-spectrum inhibitor targeting human coronavirus Mpro
Sun, J., Sun, D., Yang, Q., Wang, D., Peng, J., Guo, H., Ding, X., Zhao, C., Yuan, B., Ivanenkov, Y. A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59870-4 · Cited by 41
Generation of human tonsil epithelial organoids as an ex vivo model for SARS-CoV-2 infection
Kim, H. K., Kim, H., Lee, M. K., Choi, W. H., Jang, Y., Shin, J. S., Park, J.-Y., Bae, D. H., Hyun, S., Kim, K. H., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121460 · Cited by 44
Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery
Li, X., & Peng, T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.660710 · Cited by 38
Human Kidney Spheroids and Monolayers Provide Insights into SARS-CoV-2 Renal Interactions
Omer, D., Pleniceanu, O., Gnatek, Y., Namestnikov, M., Cohen-Zontag, O., Goldberg, S., Eden-Friedman, Y., Friedman, N., Mandelboim, M., Vitner, E. B., et al. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020111546 · Cited by 36
SARS-CoV-2 Remains Infectious on Refrigerated Deli Food, Meats, and Fresh Produce for up to 21 Days
Jia, M., Taylor, T. M., Senger, S. M., Ovissipour, R., & Bertke, A. S. (2022) · Foods · doi:10.3390/foods11030286 · Cited by 36
Tran, B. M., Grimley, S. L., McAuley, J., Hachani, A., Earnest, L., Wong, S. L., Caly, L., Druce, J. D., Purcell, D. F. J., Jackson, D. C., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020835 · Cited by 36
Gondal, A. H., Bhat, R. A., Leon-Gomez, R., Areche, F. O., & Huamán, J. T. (2022) · International Journal of Environmental Science and Technology · doi:10.1007/s13762-022-04607-9 · Cited by 41
Blanco-Melo, D., Nilsson-Payant, B. E., Uhl, S. A., Escudero-Pérez, B., Olschewski, S., Thibault, P. A., Panis, M., Rosenthal, M., Muñoz‐Fontela, C., Lee, B., et al. (2021) · Journal of Virology · doi:10.1128/jvi.02274-20 · Cited by 38
Self-citationThe Repurposed Drugs Suramin and Quinacrine Cooperatively Inhibit SARS-CoV-2 3CLpro In Vitro
Eberle, R. J., Olivier, D. S., do Amaral, M. S., Gering, I., Willbold, D., Arni, R. K., & Coronado, M. A. (2021) · Viruses · doi:10.3390/v13050873 · Cited by 36
Li, J., Ayada, I., Wang, Y., den Hoed, C. M., Kamar, N., Peppelenbosch, M. P., de Vries, A. C., Li, P., & Pan, Q. (2022) · Transplantation · doi:10.1097/tp.0000000000004256 · Cited by 36
Host-Virus Chimeric Events in SARS-CoV-2-Infected Cells Are Infrequent and Artifactual
Yan, B., Chakravorty, S., Mirabelli, C., Wang, L., Trujillo-Ochoa, J. L., Chauss, D., Kumar, D., Lionakis, M. S., Olson, M. R., Wobus, C. E., et al. (2021) · Journal of Virology · doi:10.1128/jvi.00294-21 · Cited by 35
Xu, T., Zheng, W., & Huang, R. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.05.012 · Cited by 35
Role of the Microbiome in the Pathogenesis of COVID-19
De, R., & Dutta, S. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.736397 · Cited by 35
Wang, R., Kang, N., Zhang, W., Chen, B., Xu, S., & Wu, L. (2023) · Environmental Pollution · doi:10.1016/j.envpol.2023.121764 · Cited by 34
Development of lung tissue models and their applications
Petpiroon, N., Netkueakul, W., Sukrak, K., Wang, C., Liang, Y. T., Wang, M., Liu, Y., Li, Q., Kamran, R., Naruse, K., et al. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122208 · Cited by 40
Self-citationModeling Multi-organ Infection by SARS-CoV-2 Using Stem Cell Technology
Simoneau, C. R., & Ott, M. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.11.012 · Cited by 36
Kojima, K., Yoon, H., Okishio, K., & Tsuyuguchi, K. (2023) · Scientific Reports · doi:10.1038/s41598-023-28201-2 · Cited by 34
Advances in the computational landscape for repurposed drugs against COVID-19
Aronskyy, I., Masoudi‐Sobhanzadeh, Y., Cappuccio, A., & Zaslavsky, E. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.07.026 · Cited by 33
Organoids in modelling infectious diseases
Shpichka, A. I., Bikmulina, P., Peshkova, M., Heydari, Z., Kosheleva, N. V., Vosough, M., & Timashev, P. S. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.08.005 · Cited by 35
Yamada, S., Noda, T., Okabe, K., Yanagida, S., Nishida, M., & Kanda, Y. (2022) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2022.04.010 · Cited by 33
A multi-organoid platform identifies CIART as a key factor for SARS-CoV-2 infection
Tang, X., Xue, D., Zhang, T., Nilsson-Payant, B. E., Carrau, L., Duan, X., Gordillo, M., Tan, A. Y., Qiu, Y., Xiang, J., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01095-y · Cited by 33
Self-citationIntegration of organoids in peptide drug discovery: Rise of the high‐throughput screening
Zhang, S., Shen, J., Wang, X., Sun, X., Wu, Y., Zhang, M., Wang, R., & Hu, K. (2023) · Open Research (University of Surrey) · doi:10.1002/viw.20230010 · Cited by 33
Self-citationPandamooz, S., Jurek, B., Meinung, C.-P., Baharvand, Z., Shahem-abadi, A. S., Haerteis, S., Miyan, J. A., Downing, J. R., Dianatpour, M., Borhani‐Haghighi, A., et al. (2021) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-121120-012309 · Cited by 31
Mithal, A., Hume, A. J., Lindstrom-Vautrin, J., Villacorta-Martín, C., Olejnik, J., Bullitt, E., Hinds, A., Mühlberger, E., & Mostoslavsky, G. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.02.019 · Cited by 36
In silico and in vitro evaluation of imatinib as an inhibitor for SARS-CoV-2
Mulgaonkar, N., Wang, H., Mallawarachchi, S., Růžek, D., Martina, B. E. E., & Fernando, S. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2045221 · Cited by 34
Self-citationTwo Different Therapeutic Approaches for SARS-CoV-2 in hiPSCs-Derived Lung Organoids
Spitalieri, P., Centofanti, F., Murdocca, M., Scioli, M. G., Latini, A., Cesare, S. D., Citro, G., Rossi, A., Orlandi, A., Miersch, S., et al. (2022) · Cells · doi:10.3390/cells11071235 · Cited by 31
An atlas of human viruses provides new insights into diversity and tissue tropism of human viruses
Ye, S., Lu, C., Qiu, Y., Zheng, H., Ge, X., Wu, A., Xia, Z., Jiang, T., Zhu, H., & Peng, Y. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac275 · Cited by 32
SARS-CoV-2 Infection Causes Dopaminergic Neuron SenescencePreprint
Chen, S., Han, Y., Yang, L., Kim, T., Nair, M. S., Harschnitz, O., Wang, P., Zhu, J., Koo, S. Y., Tang, X., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-513461/v1 · Cited by 31
Self-citationStem cell therapies and benefaction of somatic cell nuclear transfer cloning in COVID-19 era
Singh, B., Mal, G., Verma, V., Tiwari, R., Khan, M. I., Mohapatra, R. K., Mitra, S., Alyami, S. A., Emran, T. B., Dhama, K., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02334-5 · Cited by 30
In vitro biomimetic models for respiratory diseases: progress in lung organoids and lung-on-a-chip
Zhang, X., Liu, H., Cheng, H., Cui, Y., Junli, W., Yao, Q., Wang, P., Hu, Y., & Wang, Y. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04500-5 · Cited by 31
Self-citationChen, J., Neil, J. A., Tan, J. P., Rudraraju, R., Mohenska, M., Sun, Y., Walters, E. H., Bediaga, N. G., Sun, G., Zhou, Y., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01182-0 · Cited by 31
Lee, W., Lee, S., Yoon, J.-K., Lee, D., Kim, Y., Han, Y. B., Kim, R., Moon, S., Park, Y. J., Park, K., et al. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01076-z · Cited by 31
Self-citationEngineering organoids-on-chips for drug testing and evaluation
Wang, H., Zhu, W., Xu, C., Su, W., & Li, Z. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156065 · Cited by 32
Self-citationde Dios-Figueroa, G. T., Aguilera-Márquez, J. D. R., Camacho-Villegas, T. A., & Lugo-Fabres, P. H. (2021) · Biomedicines · doi:10.3390/biomedicines9060602 · Cited by 29
Oncogenic potential of human pluripotent stem cell‐derived lung organoids with HER2 overexpression
Miura, A., Yamada, D., Nakamura, M., Tomida, S., Shimizu, D., Jiang, Y., Takao, T., Yamamoto, H., Suzawa, K., Shien, K., et al. (2021) · International Journal of Cancer · doi:10.1002/ijc.33713 · Cited by 29
Chen, H.-Y., Huang, C., Tian, L., Huang, X., Zhang, C., Llewellyn, G. N., Rogers, G. L., Andresen, K., O’Gorman, M. R. G., Chen, Y., et al. (2021) · Journal of Virology · doi:10.1128/jvi.00966-21 · Cited by 31
Self-citation3D Human Organoids: The Next “Viral” Model for the Molecular Basis of Infectious Diseases
Chia, S. P. S., Kong, S. L. Y., Pang, J. K. S., & Soh, B.-S. (2022) · Biomedicines · doi:10.3390/biomedicines10071541 · Cited by 28
Lung Organoids as Model to Study SARS-CoV-2 Infection
Peng, L., Gao, L., Wu, X., Fan, Y., Liu, M., Chen, J., Song, J., Kong, J., Dong, Y., Li, B., et al. (2022) · Cells · doi:10.3390/cells11172758 · Cited by 29
Chu, J. T. S., & Lamers, M. M. (2024) · npj Viruses · doi:10.1038/s44298-024-00017-5 · Cited by 31
Recent advances in small-molecular therapeutics for COVID-19
Zhong, L., Zhao, Z., Peng, X., Zou, J., & Yang, S. (2022) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbac024 · Cited by 29
Self-citationHuman lung organoid: Models for respiratory biology and diseases
Yang, W., Li, Y., Shi, F., & Liu, H. (2022) · Developmental Biology · doi:10.1016/j.ydbio.2022.12.001 · Cited by 26
Murer, L., Volle, R., Andriasyan, V., Petkidis, A., Gómez-González, A., Yang, L., Meili, N., Suomalainen, M., Bauer, M., Sequeira, D. P., et al. (2022) · Current Research in Virological Science · doi:10.1016/j.crviro.2022.100019 · Cited by 25
Self-citationZheng, R., Yang, W., Wen, Y., Xie, L., Shi, F., Lu, D., Luo, J., Li, Y., Zhang, R., Chen, T., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05010-5 · Cited by 27
Shah, D. D., Raghani, N. R., Chorawala, M. R., Singh, S. K., & Prajapati, B. G. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02541-2 · Cited by 30
Advanced lung organoids and lung-on-a-chip for cancer research and drug evaluation: a review
Zhu, L., Zhang, J., Guo, Q., Kuang, J., Li, D., Wu, M., Mo, Y., Zhang, T., Gao, X., & Tan, J. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1299033 · Cited by 28
Self-citationHajjo, R., Sabbah, D. A., Abusara, O. H., Kharmah, R., & Bardaweel, S. K. (2023) · Viruses · doi:10.3390/v15020568 · Cited by 28
Metadata integrity in bioinformatics: Bridging the gap between data and knowledge
Caliskan, A., Dangwal, S., & Dandekar, T. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.10.006 · Cited by 26
Progress and pitfalls of a year of drug repurposing screens against COVID-19
Sourimant, J., Aggarwal, M., & Plemper, R. K. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.06.004 · Cited by 26
Technological advances and challenges in constructing complex gut organoid systems
Zheng, L., Zhan, Y., Wang, C., Fan, Q., Sun, D., Li, Y., & Xiong, Y. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1432744 · Cited by 27
Ge, J.-Y., Wang, Y., Li, Q., Liu, F.-K., Lei, Q.-K., & Zheng, Y. (2024) · PeerJ · doi:10.7717/peerj.18422 · Cited by 27
SARS-CoV-2 Research Using Human Pluripotent Stem Cells and Organoids
Deguchi, S., Serrano‐Aroca, Á., Tambuwala, M. M., Uhal, B. D., Brufsky, A., & Takayama, K. (2021) · Stem Cells Translational Medicine · doi:10.1002/sctm.21-0183 · Cited by 25
Scientific Validation and Clinical Application of Lung Cancer Organoids
Lee, D., Kim, Y., & Chung, C. (2021) · Cells · doi:10.3390/cells10113012 · Cited by 25
Organoid Studies in COVID-19 Research
Kim, J., Koo, B., & Clevers, H. C. (2022) · International Journal of Stem Cells · doi:10.15283/ijsc21251 · Cited by 27
Three-dimensional models of the lung: past, present and future: a mini review
Sen, C., Freund, D., & Gomperts, B. N. (2022) · Biochemical Society Transactions · doi:10.1042/bst20190569 · Cited by 25
Ahamad, S., Ali, H., Secco, I., Giacca, M., & Gupta, D. K. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.866474 · Cited by 25
Gut Microbiota and COVID-19: Potential Implications for Disease Severity
Rocchi, G., Giovanetti, M., Benedetti, F., Borsetti, A., Ceccarelli, G., Zella, D., Altomare, A., Ciccozzi, M., & Guarino, M. P. L. (2022) · Pathogens · doi:10.3390/pathogens11091050 · Cited by 27
Chen, J., & Na, F. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1066869 · Cited by 25
Rong, N., & Liu, J. (2023) · Emerging Microbes & Infections · doi:10.1080/22221751.2023.2178242 · Cited by 27
Leon‐Icaza, S. A., Bagayoko, S., Vergé, R., Iakobachvili, N., Ferrand, C., Aydogan, T., Bernard, C., Dafun, A. S., Murris‐Espin, M., Mazières, J., et al. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011559 · Cited by 29
Taverna, J. A., Hung, C., Williams, M. H., Williams, R., Chen, M., Kamali, S., Sambandam, V., Chiu, C. H.-L., Osmulski, P. A., Gaczynska, M. E., et al. (2023) · Lung Cancer · doi:10.1016/j.lungcan.2024.107533 · Cited by 26
Salas-Rojas, M., Silva‐García, R., Bini, E. I., de la Cruz, V. P., León‐Contreras, J. C., Hernández‐Pando, R., Bastida-González, F. G., Dávila-González, E., Orozco‐Morales, M., Domínguez, A. G., et al. (2021) · Viruses · doi:10.3390/v13010121 · Cited by 25
COVID-19 highlights the model dilemma in biomedical research
Adhikary, P. P., Ul Ain, Q., Hocke, A. C., & Hedtrich, S. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00305-z · Cited by 25
Eagles, N. J., Burke, E. E., Leonard, J., Barry, B. K., Stolz, J. M., Huuki-Myers, L. A., Phan, B. N., Larios‐Serrato, V., Gutiérrez-Millán, E., Aguilar-Ordóñez, I., et al. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04142-3 · Cited by 24
SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models
Kanimozhi, G., Bharathiraja, P., Pawar, C. S., Khan, H. A., Alrokayan, S., & Prasad, N. R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.638334 · Cited by 24
Wang, H., Zhang, J., Lu, Z., Dai, W., Ma, C., Xiang, Y., & Zhang, Y. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab373 · Cited by 23
Self-citationEstablishment of human distal lung organoids for SARS-CoV-2 infection
Wang, T., Zhang, N., Fan, S., Zhao, L., Song, W., Gong, Y., Shen, Q., Zhang, C., Ren, P., Lin, C., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00346-2 · Cited by 24
Peng, H., Ding, C., Jiang, L., Tang, W., Liu, Y., Zhao, L., Yi, Z., Ren, H., Li, C. V., He, Y., et al. (2021) · Science China Life Sciences · doi:10.1007/s11427-021-2031-7 · Cited by 24
Self-citationHe, X., Liu, G., Gong, J., Zhang, Y., Gu, S., Wan, Z., Yang, P., Nie, Y., Wang, Y., Huang, Z., et al. (2022) · Advanced Science · doi:10.1002/advs.202203388 · Cited by 24
3D Lung Tissue Models for Studies on SARS-CoV-2 Pathophysiology and Therapeutics
Plebani, R., Bai, H., Si, L., Li, J., Zhang, C., & Romano, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710071 · Cited by 25
SARS-CoV-2 Nsp14 protein associates with IMPDH2 and activates NF-κB signaling
Li, T.-W., Kenney, A. D., Park, J., Fiches, G. N., Liu, H., Zhou, D., Biswas, A., Zhao, W., Que, J., Santoso, N. G., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1007089 · Cited by 50
Self-citationTargeting SARS-CoV-2 and host cell receptor interactions
Lim, S. P. (2022) · Antiviral Research · doi:10.1016/j.antiviral.2022.105514 · Cited by 25
Hashimoto, R., Tamura, T., Watanabe, Y., Sakamoto, A., Yasuhara, N., Ito, H., Nakano, M., Fuse, H., Ohta, A., Noda, T., et al. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00114 · Cited by 23
Deep-Orga: An improved deep learning-based lightweight model for intestinal organoid detection
Leng, B., Jiang, H., Wang, B., Wang, J., & Luo, G. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107847 · Cited by 23
Functioning human lung organoids model pulmonary tissue response from carbon nanomaterial exposures
Issa, R., Lozano, N., Kostarelos, K., & Vranic, S. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102254 · Cited by 24
Qi, J., Wang, Y., Chen, H., Wu, K., Zhou, P., Dou, Y., Xiong, B., & Zhou, W. (2025) · Advanced Science · doi:10.1002/advs.202407802 · Cited by 23
Self-citationOrganoids: A New Model for SARS-CoV-2 Translational Research
Yu, J. S. (2021) · International Journal of Stem Cells · doi:10.15283/ijsc20169 · Cited by 23
Hu, C. (2024) · Natural Products and Bioprospecting · doi:10.1007/s13659-024-00432-4 · Cited by 24
Host-targeted antivirals against SARS-CoV-2 in clinical development - Prospect or disappointment?
Schreiber, A., & Ludwig, S. (2025) · Antiviral Research · doi:10.1016/j.antiviral.2025.106101 · Cited by 23
Science's Response to CoVID‐19
Long, M. J. C., & Aye, Y. (2021) · ChemMedChem · doi:10.1002/cmdc.202100079 · Cited by 22
Novel Dormancy Mechanism of Castration Resistance in Bone Metastatic Prostate Cancer Organoids
Lee, S., Mendoza, T. R., Burner, D. N., Muldong, M. T., Wu, C. C. N., Arreola, C., Zuniga, A., Greenburg, O., Zhu, W. Y., Murtadha, J., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063203 · Cited by 22
Cell and Animal Models for SARS-CoV-2 Research
Bestion, E., Halfon, P., Mezouar, S., & Mège, J. (2022) · Viruses · doi:10.3390/v14071507 · Cited by 24
Repurposing Drugs for the Treatment of COVID-19 and Its Cardiovascular Manifestations
Wang, R., & Loscalzo, J. (2023) · Circulation Research · doi:10.1161/circresaha.122.321879 · Cited by 23
Development of SARS-CoV-2 entry antivirals
Dong, M., Achi, J. G., Du, R., Rong, L., & Cui, Q. (2024) · Cell Insight · doi:10.1016/j.cellin.2023.100144 · Cited by 24
Lung Organoids: Systematic Review of Recent Advancements and its Future Perspectives
Thangam, T., Parthasarathy, K., Supraja, K., Haribalaji, V., Sounderrajan, V., Rao, S. S., & Jayaraj, S. (2024) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-024-00628-2 · Cited by 22
Metadata
- Authors
- Han, Y., Duan, X., Yang, L., Nilsson-Payant, B. E., Wang, P., Duan, F., Tang, X., Yaron, T. M., Zhang, T., Uhl, S., Bram, Y., Richardson, C., Zhu, J., Zhao, Z., Redmond, D., Houghton, S., Nguyen, D.-H. T., Xu, D., Wang, X., Jessurun, J., Borczuk, A., Huang, Y., Johnson, J. L., Liu, Y., Xiang, J., Wang, H., Cantley, L. C., tenOever, B. R., Ho, D. D., Pan, F. C., Evans, T., Chen, H. J., Schwartz, R. E., & Chen, S.
- Affiliations
- Weill Cornell Medicine (US)
- Shanghai Jiao Tong University (CN)
- Icahn School of Medicine at Mount Sinai (US)
- Aaron Diamond AIDS Research Center (US)
- University of Chicago (US)
- University of Illinois Chicago (US)
- Corresponding author
- Wang, Hui
- Cantley, Lewis C.
- tenOever, Benjamin R.
- Ho, David D.
- Pan, Fong Cheng
- Evans, Todd
- Chen, Huanhuan Joyce
- Schwartz, Robert E.
- Chen, Shuibing
- ORCID
- Han, Yuling
- Duan, Xiaohua
- Yang, Liuliu
- Nilsson-Payant, Benjamin E.
- Wang, Pengfei
- Duan, Fuyu
- Tang, Xuming
- Yaron, Tomer M.
- Zhang, Tuo
- Uhl, Skyler
- Bram, Yaron
- Zhu, Jiajun
- Redmond, David
- Houghton, Sean
- Nguyen, Duc-Huy T.
- Xu, Dong
- Wang, Xing
- Jessurun, Jose
- Borczuk, Alain
- Huang, Yaoxing
- Johnson, Jared L.
- Liu, Yuru
- Xiang, Jenny
- Wang, Hui
- Cantley, Lewis C.
- tenOever, Benjamin R.
- Ho, David D.
- Pan, Fong Cheng
- Evans, Todd
- Chen, Huanhuan Joyce
- Schwartz, Robert E.
- Chen, Shuibing
- Venue
- Nature
- Published
- 2020-10-28
- Volume
- 589
- Issue
- 7841
- Pages
- 270-275
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC8034380
- OpenAlex
- W3096177766
- Cited by
- 530
- References
- 33
- Citations by year
- 2026: 35 · 2025: 51 · 2024: 67 · 2023: 94 · 2022: 120 · 2021: 155 · 2020: 7
- FWCI
- 12.35
- Type
- journal article
- Language
- en
- Update notices
- correction (2024-05-29)
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- American Diabetes Association (7-20-COVID-211)
- Icahn School of Medicine at Mount Sinai
- Nature
- National Institutes of Health
- Defense Advanced Research Projects Agency (W911NF‐16‐C‐0050)
- Weill Cornell Medical College
- Advanced Research Projects Agency
- National Cancer Institute (R00CA226353, R01CA234614)
- National Institute of Allergy and Infectious Diseases (R01AI107301)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK124463, R01DK116075, R01DK119667, 1RO3DK117252, R01DK121072, DP3DK111907, R03DK117252)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Keywords
- SARS-CoV-2, COVID-19 pandemic, lung organoids, colonic organoids, human pluripotent stem cells, alveolar type II cells, enterocytes, ACE2 expression, entry inhibitors, imatinib, mycophenolic acid, high-throughput drug screening, FDA-approved drugs, antiviral activity, chemokine induction, gastrointestinal manifestations of COVID-19
- MeSH terms
- COVID-19, SARS-CoV-2, COVID-19 Drug Treatment, Animals, Antiviral Agents, Colon, Drug Evaluation, Preclinical, Female, Humans, Lung, Male, Organoids, United States, United States Food and Drug Administration, Drug Approval, Mice, Virus Internalization, Viral Tropism, Heterografts, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
